• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    More On IDIX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Idenix Pharmaceuticals, Inc. (IDIX)

    -NasdaqGS
    24.50 0.00(0.00%) Aug 5, 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.4
    Mean Recommendation (last week):2.5
    Change:-0.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:21.50
    Median Target:24.50
    High Target:25.00
    Low Target:9.00
    No. of Brokers:5

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jun 9, 2014Robert W. BairdUpgradeNeutralOutperform
    Jun 21, 2013Robert W. BairdDowngradeNeutralUnderperform
    Feb 12, 2013Robert W. BairdInitiated Neutral
    Nov 28, 2012Deutsche BankInitiated Buy
    Nov 12, 2012Maxim GroupDowngradeBuyHold
    Jun 14, 2012Maxim GroupInitiated Buy
    Apr 30, 2012JMP SecuritiesUpgradeMkt UnderperformMkt Perform
    Feb 10, 2012Barclays CapitalInitiated Equal Weight
    Jan 27, 2012Stifel NicolausDowngradeHoldSell
    Feb 10, 2011OppenheimerDowngradeOutperformPerform

    More Upgrades & Downgrades for IDIX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000
    Buy0000
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.